Induction of NK cell reactivity against AML and CLL cells by Fc-engineered GITR-Fc fusion proteins

被引：0
|
作者：
Hilpert, J. [1 ]
Schmiedel, B. J. [1 ]
Werner, A. [1 ]
Nuebling, T. [1 ]
Buechele, C. [1 ]
Grosse-Hovest, L. [2 ]
Kanz, L. [1 ]
Salih, H. R. [1 ]
机构：
[1] Univ Tubingen, Dept Hematol & Oncol, Tubingen, Germany
[2] Univ Tubingen, Dept Immunol, Tubingen, Germany
来源：
ONKOLOGIE | 2012年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：57 / 58
页数：2
相关论文
共 50 条
  • [41] An Fc-Optimized CD133 Antibody for Induction of Natural Killer Cell Reactivity Against Colorectal Cancer
    Schmied, Bastian J.
    Riegg, Fabian
    Zekri, Latifa
    Grosse-Hovest, Ludger
    Buehring, Hans-Joerg
    Jung, Gundram
    Salih, Helmut R.
    CANCERS, 2019, 11 (06):
  • [42] The Fc-engineered CD19 antibody MOR208 (XmAb5574) induces NK cell-mediated lysis of acute lymphoblastic leukemia cells from pediatric and adult patients
    Kellner, C.
    Zhukovsky, E. A.
    Brueggemann, M.
    Poetzke, A.
    Schrauder, A.
    Kneba, M.
    Repp, R.
    Humpe, A.
    Gramatzki, M.
    Peipp, M.
    ONKOLOGIE, 2012, 35 : 185 - 185
  • [43] Generation and Preclinical Characterization of an NKp80-Fc Fusion Protein for Redirected Cytolysis of Natural Killer (NK) Cells against Leukemia
    Deng, Gang
    Zheng, Xiaodong
    Zhou, Jing
    Wei, Haiming
    Tian, Zhigang
    Sun, Rui
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (37) : 22474 - 22484
  • [44] Enhanced potency of immunotherapy against B-cell precursor acute lymphoblastic leukemia by combination of an Fc-engineered CD19 antibody and CD47 blockade
    Schewe, Denis M.
    Vogiatzi, Fotini
    Muennich, Ira A.
    Zeller, Tobias
    Windisch, Roland
    Wichmann, Christian
    Mueller, Kristina
    Bhat, Hilal
    Felix, Elisa
    Mougiakakos, Dimitrios
    Bruns, Heiko
    Lenk, Lennart
    Valerius, Thomas
    Humpe, Andreas
    Peipp, Matthias
    Kellner, Christian
    HEMASPHERE, 2024, 8 (02):
  • [45] Immunocytokines with Target Cell-Restricted IL-15 Activity for Induction of NK Cell Reactivity Against Acute Myeloid Leukemia (AML)
    Schmied, Bastian J.
    Zekri, Latifa
    Pfluegler, Martin
    Maerklin, Melanie
    Kanz, Lothar
    Jung, Gundram
    Salih, Helmut R.
    BLOOD, 2018, 132
  • [46] A novel Fc-engineered cathepsin D-targeting antibody enhances ADCC, triggers tumor-infiltrating NK cell recruitment, and improves treatment with paclitaxel and enzalutamide in triple-negative breast cancer
    du Roure, Penelope Desroys
    Lajoie, Laurie
    Mallavialle, Aude
    Alcaraz, Lindsay B.
    Mansouri, Hanane
    Fenou, Lise
    Garambois, Veronique
    Rubio, Lucie
    David, Timothee
    Coenon, Lois
    Boissiere-Michot, Florence
    Chateau, Marie-Christine
    Ngo, Giang
    Jarlier, Marta
    Villalba, Martin
    Martineau, Pierre
    Laurent-Matha, Valerie
    Roger, Pascal
    Guiu, Severine
    Chardes, Thierry
    Gros, Laurent
    Liaudet-Coopman, Emmanuelle
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (01)
  • [47] Generation of new peptide-Fc fusion proteins that mediate antibody-dependent cellular cytotoxicity against different types of cancer cells
    Sioud, Mouldy
    Westby, Phuong
    Olsen, Julie Kristine E.
    Mobergslien, Anne
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2015, 2 : 15043
  • [48] CRACC-targeting Fc-fusion protein induces activation of NK cells and DCs and improves T cell immune responses to antigenic targets
    Aldhamen, Yasser A.
    Rastall, David P. W.
    Chen, Weimin
    Seregin, Sergey S.
    Pereira-Hicks, Cristiane
    Godbehere, Sarah
    Kaminski, Norbert E.
    Amalfitano, Andrea
    VACCINE, 2016, 34 (27) : 3109 - 3118
  • [49] XmAb5574: In vitro and in vivo efficacy of an Fc-engineered anti-CD19 monoclonal antibody against lymphoma and leukemia and its effect on B cells in non-human primates
    Zhukovsky, E.
    Horton, H.
    Lawrence, C. E.
    Chu, S.
    Pong, E.
    Richards, J.
    Peipp, M.
    Repp, R.
    Desjarlais, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [50] Carcinoembryonic antigen-immunoglobulin Fc fusion protein (CEA-Fc) for identification and activation of anti-CEA immunoglobulin-T-cell receptor-modified T cells, representative of a new class of Ig fusion proteins
    Ma, QZ
    DeMarte, L
    Wang, YW
    Stanners, CP
    Junghans, RP
    CANCER GENE THERAPY, 2004, 11 (04) : 297 - 306
12345